2020 Q2 Form 10-Q Financial Statement

#000109714920000049 Filed on July 31, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $352.3M $600.7M $549.0M
YoY Change -41.35% 22.52% 25.64%
Cost Of Revenue $128.0M $168.4M $146.9M
YoY Change -24.0% 35.08% 34.11%
Gross Profit $224.3M $432.3M $402.1M
YoY Change -48.11% 18.25% 22.81%
Gross Profit Margin 63.67% 71.96% 73.25%
Selling, General & Admin $257.0M $267.9M $247.1M
YoY Change -4.1% 26.34% 23.79%
% of Gross Profit 114.55% 61.98% 61.46%
Research & Development $40.36M $38.85M $37.50M
YoY Change 3.89% 26.12% 26.74%
% of Gross Profit 17.99% 8.99% 9.33%
Depreciation & Amortization $23.55M $19.17M $18.32M
YoY Change 22.81% 51.77% 60.19%
% of Gross Profit 10.5% 4.43% 4.56%
Operating Expenses $297.3M $255.8M $314.4M
YoY Change 16.24% 5.31% 37.16%
Operating Profit -$73.00M $176.5M $87.70M
YoY Change -141.36% 43.85% -10.68%
Interest Expense $500.0K $3.500M $2.200M
YoY Change -85.71% 84.21% 0.0%
% of Operating Profit 1.98% 2.51%
Other Income/Expense, Net -$966.0K $13.89M -$5.746M
YoY Change -106.95% -295.69% -3346.33%
Pretax Income -$73.49M $193.8M $84.59M
YoY Change -137.91% 64.96% -15.87%
Income Tax -$32.90M $43.10M $8.800M
% Of Pretax Income 22.23% 10.4%
Net Earnings -$40.60M $147.1M $71.85M
YoY Change -127.59% 38.68% -25.05%
Net Earnings / Revenue -11.52% 24.5% 13.09%
Basic Earnings Per Share -$0.52 $1.84 $0.90
Diluted Earnings Per Share -$0.52 $1.83 $0.89
COMMON SHARES
Basic Shares Outstanding 78.77M shares 79.94M shares 79.86M shares
Diluted Shares Outstanding 78.77M shares 80.59M shares 80.69M shares

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $404.4M $720.9M $732.5M
YoY Change -43.91% 1.16% 10.53%
Cash & Equivalents $404.4M $423.5M $588.0M
Short-Term Investments $0.00 $297.4M $144.5M
Other Short-Term Assets $24.96M $18.97M $116.8M
YoY Change 31.57% -85.04% 7.45%
Inventory $131.3M $81.12M $68.49M
Prepaid Expenses
Receivables $473.3M $520.1M $479.3M
Other Receivables $118.8M $18.83M $0.00
Total Short-Term Assets $1.149B $1.457B $1.439B
YoY Change -21.14% 15.57% 23.13%
LONG-TERM ASSETS
Property, Plant & Equipment $669.0M $599.6M $575.3M
YoY Change 11.56% 33.86% 43.63%
Goodwill $415.5M
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.100M $50.90M $42.00M
YoY Change -95.87% 3.61% -20.45%
Other Assets $27.58M $48.89M $26.19M
YoY Change -43.59% 153.3% 51.95%
Total Long-Term Assets $2.877B $888.6M $795.3M
YoY Change 223.71% 35.55% 29.54%
TOTAL ASSETS
Total Short-Term Assets $1.149B $1.457B $1.439B
Total Long-Term Assets $2.877B $888.6M $795.3M
Total Assets $4.026B $2.346B $2.234B
YoY Change 71.6% 22.41% 25.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $94.99M $61.95M $62.51M
YoY Change 53.33% 27.09% 49.26%
Accrued Expenses $244.8M $245.6M $252.8M
YoY Change -0.35% 24.84% 40.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $56.10M
YoY Change
Total Short-Term Liabilities $941.6M $789.0M $804.9M
YoY Change 19.33% 39.25% 55.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $73.34M $25.97M $21.07M
YoY Change 182.45% 69.91% 17.48%
Total Long-Term Liabilities $73.34M $25.97M $21.07M
YoY Change 182.45% 69.91% 17.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $941.6M $789.0M $804.9M
Total Long-Term Liabilities $73.34M $25.97M $21.07M
Total Liabilities $1.181B $972.3M $978.7M
YoY Change 21.44% 39.38% 49.36%
SHAREHOLDERS EQUITY
Retained Earnings $1.917B $501.3M $402.0M
YoY Change 282.51% 34.23% 50.38%
Common Stock $8.000K $8.000K $8.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.845B $1.374B $1.256B
YoY Change
Total Liabilities & Shareholders Equity $4.026B $2.346B $2.234B
YoY Change 71.6% 22.41% 25.34%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$40.60M $147.1M $71.85M
YoY Change -127.59% 38.68% -25.05%
Depreciation, Depletion And Amortization $23.55M $19.17M $18.32M
YoY Change 22.81% 51.77% 60.19%
Cash From Operating Activities $59.90M $177.4M $117.2M
YoY Change -66.23% 26.9% 51.56%
INVESTING ACTIVITIES
Capital Expenditures -$34.40M -$45.30M $27.00M
YoY Change -24.06% -21.49% -53.11%
Acquisitions
YoY Change
Other Investing Activities -$414.1M -$201.2M $2.367M
YoY Change 105.82% -8148.0% -612.34%
Cash From Investing Activities -$448.5M -$246.6M -$74.42M
YoY Change 81.87% 345.93% -168.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $40.39M
YoY Change -56.09%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.700M -95.60M -$92.76M
YoY Change -98.22% 209.39% -33.66%
NET CHANGE
Cash From Operating Activities 59.90M 177.4M $117.2M
Cash From Investing Activities -448.5M -246.6M -$74.42M
Cash From Financing Activities -1.700M -95.60M -$92.76M
Net Change In Cash -390.3M -164.8M -$48.88M
YoY Change 136.83% -407.46% -200.8%
FREE CASH FLOW
Cash From Operating Activities $59.90M $177.4M $117.2M
Capital Expenditures -$34.40M -$45.30M $27.00M
Free Cash Flow $94.30M $222.7M $90.21M
YoY Change -57.66% 12.76% 356.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Local Phone Number
LocalPhoneNumber
470-1000
dei Entity Central Index Key
EntityCentralIndexKey
0001097149
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-32259
dei Entity Registrant Name
EntityRegistrantName
ALIGN TECHNOLOGY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3267295
dei Entity Address Address Line1
EntityAddressAddressLine1
2820 Orchard Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95134
dei City Area Code
CityAreaCode
408
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
ALGN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78786683 shares
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
352314000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
600697000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
903277000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1149668000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
127986000 USD
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
168408000 USD
us-gaap Cost Of Revenue
CostOfRevenue
284593000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
224328000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19515000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
29782000 USD
us-gaap Cost Of Revenue
CostOfRevenue
315283000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
432289000 USD
us-gaap Gross Profit
GrossProfit
618684000 USD
us-gaap Gross Profit
GrossProfit
834385000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
256967000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
267948000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
539873000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
515058000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40361000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38851000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
81893000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
76354000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2019Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
51000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
51000000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
297328000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
255799000 USD
us-gaap Operating Expenses
OperatingExpenses
621766000 USD
us-gaap Operating Expenses
OperatingExpenses
570194000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-73000000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
176490000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3082000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
264191000 USD
CY2020Q2 us-gaap Interest Income Other
InterestIncomeOther
473000 USD
CY2019Q2 us-gaap Interest Income Other
InterestIncomeOther
3465000 USD
us-gaap Interest Income Other
InterestIncomeOther
2459000 USD
us-gaap Interest Income Other
InterestIncomeOther
6098000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-966000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13892000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8146000 USD
CY2020Q2 algn Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-493000 USD
CY2019Q2 algn Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
17357000 USD
algn Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-17056000 USD
algn Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
14244000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-73493000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
193847000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20138000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
278435000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-32891000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43121000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1497667000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51917000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3584000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
112051000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7528000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-40602000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
147142000 USD
us-gaap Net Income Loss
NetIncomeLoss
1477529000 USD
us-gaap Net Income Loss
NetIncomeLoss
218990000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
18.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.74
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
18.70
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.71
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78769000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79943000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78681000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79901000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78769000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80590000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79016000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80665000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-40602000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
147142000 USD
us-gaap Net Income Loss
NetIncomeLoss
1477529000 USD
us-gaap Net Income Loss
NetIncomeLoss
218990000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9294000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
213000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9983000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
622000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
192000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-194000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
276000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9294000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
405000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9789000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
898000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31308000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
147547000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1487318000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
219888000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
404359000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
550425000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
318202000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
17099000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6756000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
473314000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
550291000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
131276000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
140295000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
102450000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
1149244000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1633419000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
668951000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
631730000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68578000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56244000 USD
CY2020Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
543211000 USD
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
75692000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1568293000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
64007000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27580000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39610000 USD
CY2020Q2 us-gaap Assets
Assets
4025857000 USD
CY2019Q4 us-gaap Assets
Assets
2500702000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
94987000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
87250000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
244774000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
319958000 USD
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
601831000 USD
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
563762000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
941592000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
970970000 USD
CY2020Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
115257000 USD
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
102794000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50619000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43463000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
73344000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
37306000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
1180812000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1154533000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78781000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78781000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78433000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78433000 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
918495000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
906937000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9101000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-688000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1917441000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
439912000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2845045000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1346169000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4025857000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2500702000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
2852989000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-40602000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-40602000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9294000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q2 algn Tax Withholding Related To Vesting Of Equity Awards
TaxWithholdingRelatedToVestingOfEquityAwards
1643000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25007000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2845045000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1346169000 USD
us-gaap Net Income Loss
NetIncomeLoss
1477529000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-194000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9983000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10662000 USD
algn Tax Withholding Related To Vesting Of Equity Awards
TaxWithholdingRelatedToVestingOfEquityAwards
47038000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47934000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2845045000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1255704000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
147142000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
192000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
213000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5000 USD
CY2019Q2 algn Tax Withholding Related To Vesting Of Equity Awards
TaxWithholdingRelatedToVestingOfEquityAwards
2537000 USD
CY2019Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
49504000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22467000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1373682000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1252891000 USD
us-gaap Net Income Loss
NetIncomeLoss
218990000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
276000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
622000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9614000 USD
algn Tax Withholding Related To Vesting Of Equity Awards
TaxWithholdingRelatedToVestingOfEquityAwards
52718000 USD
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
99504000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43511000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1373682000 USD
us-gaap Net Income Loss
NetIncomeLoss
1477529000 USD
us-gaap Net Income Loss
NetIncomeLoss
218990000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1504251000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5606000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44283000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37488000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
47934000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
43511000 USD
algn Lessee Operating Leases Noncash Operating Costs
LesseeOperatingLeasesNoncashOperatingCosts
11148000 USD
algn Lessee Operating Leases Noncash Operating Costs
LesseeOperatingLeasesNoncashOperatingCosts
8681000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
12578000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
3240000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
3787000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
3975000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
28498000 USD
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 USD
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
15769000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7528000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-11542000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-9548000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-64645000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
89055000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21398000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26681000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
31058000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
48949000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11918000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1847000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-106572000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1321000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
6707000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
9608000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40892000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
95174000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
69684000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
294561000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
420788000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
80502000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
80598000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
5341000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
353995000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
42641000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
107021000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
278817000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
14456000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
11087000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
6598000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1760000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
14502000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-172326000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-321020000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10662000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9614000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
99504000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
47038000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
52718000 USD
algn Purchase Of Finance Lease
PurchaseOfFinanceLease
0 USD
algn Purchase Of Finance Lease
PurchaseOfFinanceLease
45773000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-36376000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-188381000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-7172000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1467000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-146190000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-213373000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551134000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
637566000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
131276000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
404944000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
424193000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:18pt;text-align:justify;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:22.5pt;text-align:justify;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the U.S. requires our management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, useful lives of intangible assets and property and equipment, long-lived assets and goodwill, income taxes and contingent liabilities, the fair values of financial instruments, stock-based compensation, unsecured promissory note receivable, and valuation of investments in privately held companies among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-indent:18pt;text-align:justify;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Certain Risks and Uncertainties</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:22.5pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Due to the COVID-19 pandemic, we are subject to a greater degree of uncertainty than normal in making the judgments and estimates needed to apply our significant accounting policies. As the COVID-19 pandemic continues to be a global issue, we may make changes to these estimates and judgments, which could result in meaningful impacts to our financial statements in future periods. The extent and duration of the impact of the COVID-19 pandemic on our business is highly uncertain and difficult to predict and the response to the pandemic is rapidly evolving. The severity of the impact of the COVID-19 pandemic on our business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on our customers, all of which are uncertain and cannot be predicted. Our future results of operations and liquidity could be adversely impacted by delays in payments of outstanding receivable amounts beyond normal payment terms, supply chain disruptions and uncertain demand, and the impact of any initiatives or programs that we may undertake to address financial and operations challenges faced by us or our customers. Additionally, the uncertainty of future results and cash flows may impact our significant assumptions and estimates including the collectability of accounts and other receivables and realization of our deferred tax assets. As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic may materially impact our financial condition, liquidity, or results of operations is uncertain.</span></div>
algn Debt Securities Maximum Effective Maturity Period
DebtSecuritiesMaximumEffectiveMaturityPeriod
P40M
CY2019Q4 algn Marketable Securities Weighted Average Remaining Maturity At Period End
MarketableSecuritiesWeightedAverageRemainingMaturityAtPeriodEnd
P7M
CY2020Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2100000 USD
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
5900000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
3800000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
4000000.0 USD
CY2020Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
3000000.0 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
12700000 USD
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
73183000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
54947000 USD
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
32232000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
30974000 USD
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
25861000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
26130000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
112051000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
55502000 USD
CY2020Q2 algn Tax Related Receivables
TaxRelatedReceivables
72481000 USD
CY2019Q4 algn Tax Related Receivables
TaxRelatedReceivables
41252000 USD
CY2020Q2 algn Prepaid Software And Maintenance
PrepaidSoftwareAndMaintenance
21543000 USD
CY2019Q4 algn Prepaid Software And Maintenance
PrepaidSoftwareAndMaintenance
7128000 USD
CY2020Q2 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
21314000 USD
CY2019Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
25005000 USD
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
24957000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
29065000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
140295000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
102450000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
82256000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
162486000 USD
CY2020Q2 algn Accrued Expenses
AccruedExpenses
55844000 USD
CY2019Q4 algn Accrued Expenses
AccruedExpenses
55529000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20860000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15737000 USD
CY2020Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
19506000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
10410000 USD
CY2020Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
11733000 USD
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
9089000 USD
CY2020Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11629000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11205000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
42946000 USD
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
601831000 USD
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
563762000 USD
CY2020Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
36142000 USD
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
35503000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
352300000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
600700000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
903300000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1100000000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
651900000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
63924000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
344238000 USD
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
7374000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
415536000 USD
CY2019Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
61853000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
127675000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4100000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
186814000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
39881000 USD
CY2020Q2 algn Finite Lived Intangible Assets Accumulated Impairment Loss
FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss
19258000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
127675000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
68114000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37088000 USD
CY2019Q4 algn Finite Lived Intangible Assets Accumulated Impairment Loss
FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss
19258000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11768000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8178000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
15899000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14642000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
14022000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
13081000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
244774000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
319958000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11205000 USD
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
8551000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5820000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
6000000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
5396000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
4052000 USD
CY2020Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11629000 USD
CY2019Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
10499000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5400000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000.0 USD
CY2019Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
15800000 USD
CY2019Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
14200000 USD
CY2019Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
14300000 USD
CY2019Q1 us-gaap Severance Costs1
SeveranceCosts1
1300000 USD
CY2019Q4 us-gaap Contractual Obligation
ContractualObligation
36000000.0 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25007000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22467000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
47934000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43511000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.417
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.486
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.015
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.025
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
80.54
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
90.36
algn Effective Income Tax Rate Reconciliation Tax Benefit On Transfer Of Assets Amount
EffectiveIncomeTaxRateReconciliationTaxBenefitOnTransferOfAssetsAmount
1493500000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-32900000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43100000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.448
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.222
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1497700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51900000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
74.370
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.186
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
57000000.0 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
46700000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
35400000 USD
CY2019Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
452600000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
147142000 USD
us-gaap Net Income Loss
NetIncomeLoss
1477529000 USD
us-gaap Net Income Loss
NetIncomeLoss
218990000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78769000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79943000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78681000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79901000 shares
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
647000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
335000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
764000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78769000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80590000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79016000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80665000 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
18.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.74
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
18.70
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.71
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
733000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
139000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
231000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
111000 shares
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13199000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
12202000 USD
algn Notes Issued Issued In Sale Of Equity Method Investment
NotesIssuedIssuedInSaleOfEquityMethodInvestment
0 USD
algn Notes Issued Issued In Sale Of Equity Method Investment
NotesIssuedIssuedInSaleOfEquityMethodInvestment
54154000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
12817000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
9020000 USD
algn Finance Lease Purchase Payment Related To Third Party Lease
FinanceLeasePurchasePaymentRelatedToThirdPartyLease
0 USD
algn Finance Lease Purchase Payment Related To Third Party Lease
FinanceLeasePurchasePaymentRelatedToThirdPartyLease
10896000 USD
algn Purchase Of Finance Lease
PurchaseOfFinanceLease
0 USD
algn Purchase Of Finance Lease
PurchaseOfFinanceLease
45773000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
25545000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
21066000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
51064000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
352314000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
600697000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
903277000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1149668000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
224328000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
432289000 USD
us-gaap Gross Profit
GrossProfit
618684000 USD
us-gaap Gross Profit
GrossProfit
834385000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-73000000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
176490000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3082000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
264191000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23545000 USD
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19172000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44283000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37488000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
29782000 USD
CY2020Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2019Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
51000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
51000000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-73000000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
176490000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3082000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
264191000 USD
CY2020Q2 us-gaap Interest Income Other
InterestIncomeOther
473000 USD
CY2019Q2 us-gaap Interest Income Other
InterestIncomeOther
3465000 USD
us-gaap Interest Income Other
InterestIncomeOther
2459000 USD
us-gaap Interest Income Other
InterestIncomeOther
6098000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-966000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13892000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19515000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8146000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-73493000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
193847000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20138000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
278435000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
352314000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
600697000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
903277000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1149668000 USD
CY2020Q2 algn Property Plant And Equipment And Rou Assets
PropertyPlantAndEquipmentAndROUAssets
737529000 USD
CY2019Q4 algn Property Plant And Equipment And Rou Assets
PropertyPlantAndEquipmentAndROUAssets
687974000 USD

Files In Submission

Name View Source Status
0001097149-20-000049-index-headers.html Edgar Link pending
0001097149-20-000049-index.html Edgar Link pending
0001097149-20-000049.txt Edgar Link pending
0001097149-20-000049-xbrl.zip Edgar Link pending
algn-20200630.htm Edgar Link pending
algn-20200630.xsd Edgar Link pending
algn-20200630xex311.htm Edgar Link pending
algn-20200630xex312.htm Edgar Link pending
algn-20200630xex321.htm Edgar Link pending
algn-20200630_cal.xml Edgar Link unprocessable
algn-20200630_def.xml Edgar Link unprocessable
algn-20200630_g1.jpg Edgar Link pending
algn-20200630_htm.xml Edgar Link completed
algn-20200630_lab.xml Edgar Link unprocessable
algn-20200630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending